Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
grade B 32.18 -3.48% -1.16
KRYS closed down 3.48 percent on Monday, May 20, 2019, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical KRYS trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -3.48%
20 DMA Support Bullish -3.48%
1,2,3 Pullback Bullish Bullish Swing Setup -3.48%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.48%

Older signals for KRYS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Medicine Rare Diseases Gene Therapy Medical Genetics Genetic Genealogy Genodermatoses Herpes Simplex Virus Epidermolysis Bullosa Itchiness
Is KRYS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 38.95
52 Week Low 10.0
Average Volume 104,884
200-Day Moving Average 22.9795
50-Day Moving Average 30.233
20-Day Moving Average 33.244
10-Day Moving Average 33.965
Average True Range 1.851
ADX 30.41
+DI 27.8607
-DI 20.2367
Chandelier Exit (Long, 3 ATRs ) 33.397
Chandelier Exit (Short, 3 ATRs ) 35.343
Upper Bollinger Band 36.0518
Lower Bollinger Band 30.4362
Percent B (%b) 0.31
BandWidth 16.892071
MACD Line 0.9023
MACD Signal Line 1.1361
MACD Histogram -0.2339
Fundamentals Value
Market Cap 310.33 Million
Num Shares 9.64 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -51.08
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.97
Resistance 3 (R3) 34.11 33.65 33.67
Resistance 2 (R2) 33.65 33.20 33.58 33.57
Resistance 1 (R1) 32.92 32.92 32.69 32.78 33.47
Pivot Point 32.46 32.46 32.35 32.39 32.46
Support 1 (S1) 31.73 32.01 31.50 31.59 30.89
Support 2 (S2) 31.27 31.73 31.20 30.79
Support 3 (S3) 30.54 31.27 30.69
Support 4 (S4) 30.40